AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$392M |
| 2 |
Qualcomm
QCOM
|
+$262M |
| 3 |
Microsoft
MSFT
|
+$260M |
| 4 |
Illumina
ILMN
|
+$259M |
| 5 |
International Flavors & Fragrances
IFF
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$341M |
| 2 |
Biogen
BIIB
|
+$295M |
| 3 |
Apple
AAPL
|
+$289M |
| 4 |
Booking.com
BKNG
|
+$207M |
| 5 |
CELG
Celgene Corp
CELG
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 15.41% |
| 3 | Financials | 15.33% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Gorman-Rupp
GRC
$2.13B
| $890K | ﹤0.01% |
23,745
+296
| +1% | +$10.8K |
|
2327
AngioDynamics
ANGO
$565M
| $884K | ﹤0.01% |
55,200
-35,770
| -39% | -$546K |
|
2328
ATN International
ATNI
$364M
| $878K | ﹤0.01% |
15,860
+100
| +0.6% | +$5.69K |
|
2329
Quince Therapeutics
QNCX
$17.5M
| $876K | ﹤0.01% |
78
+32
| +70% | +$193K |
|
|
MBCN
2330
DELISTED
Middlefield Banc Corp
MBCN
| $875K | ﹤0.01% |
+33,526
| New | +$824K |
|
2331
Universal Electronics
UEIC
$57.6M
| $874K | ﹤0.01% |
16,720
+100
| +0.6% | +$5.36K |
|
2332
Select Water Solutions
WTTR
$2.34B
| $873K | ﹤0.01% |
94,032
-709
| -0.7% | -$5.72K |
|
|
LBAI
2333
DELISTED
Lakeland Bancorp Inc
LBAI
| $870K | ﹤0.01% |
50,045
| – | – |
|
2334
Ovintiv
OVV
$16.6B
| $869K | ﹤0.01% |
37,078
-1,801
| -5% | -$38.6K |
|
|
STXB
2335
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $867K | ﹤0.01% |
37,714
| – | – |
|
2336
Ares Capital
ARCC
$13.6B
| $866K | ﹤0.01% |
46,449
+3,727
| +9% | +$69.2K |
|
2337
Rhinebeck Bancorp
RBKB
$192M
| $864K | ﹤0.01% |
76,383
+31,983
| +72% | +$344K |
|
2338
Penske Automotive Group
PAG
$14.2B
| $859K | ﹤0.01% |
17,100
+1,500
| +10% | +$74.2K |
|
|
CNST
2339
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $857K | ﹤0.01% |
+18,200
| New | +$525K |
|
2340
MGP Ingredients
MGPI
$384M
| $855K | ﹤0.01% |
17,650
+50
| +0.3% | +$2.34K |
|
2341
Midland States Bancorp
MSBI
$681M
| $852K | ﹤0.01% |
29,420
| – | – |
|
2342
Rocket Pharmaceuticals
RCKT
$355M
| $851K | ﹤0.01% |
37,400
-3,900
| -9% | -$65.1K |
|
2343
iShares US Healthcare ETF
IYH
$3.38B
| $848K | ﹤0.01% |
19,665
-75
| -0.4% | -$3.03K |
|
2344
CAE Inc. Common Shares
CAE
$8.3B
| $847K | ﹤0.01% |
32,023
-630
| -2% | -$16.2K |
|
|
NPKI
2345
NPK International
NPKI
$1.19B
| $841K | ﹤0.01% |
134,144
+500
| +0.4% | +$3.26K |
|
2346
iShares Currency Hedged MSCI Japan ETF
HEWJ
$731M
| $837K | ﹤0.01% |
25,374
-5,026
| -17% | -$165K |
|
2347
Entravision Communication
EVC
$1.02B
| $834K | ﹤0.01% |
318,500
-189,390
| -37% | -$517K |
|
|
FFG
2348
DELISTED
FBL Financial Group
FFG
| $834K | ﹤0.01% |
14,160
-500
| -3% | -$28.8K |
|
2349
Autoliv
ALV
$8.76B
| $832K | ﹤0.01% |
9,861
-8,487
| -46% | -$694K |
|
2350
Ichor Holdings
ICHR
$2.73B
| $832K | ﹤0.01% |
25,012
+4,662
| +23% | +$139K |
|
Similar funds
AllianceBernstein's Q4 2019 Portfolio in Review
As of Q4 2019, AllianceBernstein held 3,209 positions worth $176B, up 9.6% from $161B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.6%. AllianceBernstein opened 57 new positions and exited 91, leaving the 3,209-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2019 buy was Tradeweb Markets: 1,191,306 shares worth $55.2M.
- AllianceBernstein added most to Nike in Q4 2019, an estimated $392M increase.
- AllianceBernstein's biggest Q4 2019 reduction was JPMorgan Chase, cutting an estimated $341M.
- AllianceBernstein fully exited Celgene Corp in Q4 2019, selling an estimated $194M.
- AllianceBernstein's ten largest holdings make up 19% of its $176B portfolio in Q4 2019.
- AllianceBernstein opened 57 new positions and closed 91 in Q4 2019.
- AllianceBernstein's portfolio value rose 9.6% quarter-over-quarter to $176B.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.